✦ LIBER ✦

W1324 Medium Term Efficacy, Mucosal Healing and Safety of Adalimumab Therapy in Patients With Crohn's Disease. National Data From Hungary

✍ Scribed by Czegledi, Zsofia; Miheller, Pál; Molnar, Tamas; Lakatos, Laszlo; Vincze, Aron; Palatka, Karoly; Gasztonyi, Beata; Salamon, Agnes; Horvath, Gabor; Farkas, Klaudia; Szamosi, Tamas; Banai, Janos; Tulassay, Zsolt; Papp, Maria; Altorjay, Istvan; Nagy, Ferenc; Lakatos, Peter L.

Book ID: 121907459
Publisher: Elsevier Science
Year: 2010
Tongue: English
Weight: 46 KB
Volume: 138
Category: Article
ISSN: 0016-5085
DOI: 10.1016/S0016-5085(10)63215-5

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

P572 Adalimumab achieves efficacy in muc

P572 Adalimumab achieves efficacy in mucosal healing regardless of baseline disease severity in patients with Crohn's disease: Data from EXTEND

✍ Sandborn, W.J.; Wolf, D.; Colombel, J.-F.; Panes, J.; Eichner, S.; Iezzi, A.; Zh 📂 Article 📅 2014 🏛 Oxford University Press 🌐 English ⚖ 191 KB

Mo1219 Adalimumab Achieves Efficacy in M

Mo1219 Adalimumab Achieves Efficacy in Mucosal Healing Regardless of Baseline Disease Severity in Patients With Crohn's Disease: Data From EXTEND

✍ Sandborn, William; Wolf, Douglas C.; Colombel, Jean-Frederic; Panes, Julian; Eic 📂 Article 📅 2014 🏛 Elsevier Science 🌐 English ⚖ 321 KB